{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "26940418",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20260709",
      "reporttype": "1",
      "serious": "1",
      "seriousnessdeath": "2",
      "seriousnesslifethreatening": "2",
      "seriousnesshospitalization": "2",
      "seriousnessdisabling": "2",
      "seriousnesscongenitalanomali": "2",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20260630",
      "receiptdateformat": "102",
      "receiptdate": "20260630",
      "fulfillexpeditecriteria": "2",
      "companynumb": "US-NOVOPROD-3632666",
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "6",
        "senderorganization": "NOVO NORDISK A/S"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "29.0",
            "reactionmeddrapt": "Impaired gastric emptying",
            "reactionoutcome": "3"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "OZEMPIC",
            "drugbatchnumb": "B2ADAG4",
            "drugauthorizationnumb": "209637",
            "drugseparatedosagenumb": "1",
            "drugindication": "Type 2 diabetes mellitus",
            "actiondrug": "4",
            "activesubstance": {
              "activesubstancename": "SEMAGLUTIDE"
            },
            "openfda": {
              "application_number": [
                "NDA213051"
              ],
              "brand_name": [
                "OZEMPIC"
              ],
              "generic_name": [
                "ORAL SEMAGLUTIDE"
              ],
              "manufacturer_name": [
                "Novo Nordisk Pharmaceutical Industries, LP"
              ],
              "product_ndc": [
                "0169-1704",
                "0169-1715",
                "0169-1709",
                "0169-4303",
                "0169-4307",
                "0169-4314",
                "0169-4815",
                "0169-4804",
                "0169-4809"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "SEMAGLUTIDE"
              ],
              "rxcui": [
                "2200644",
                "2200650",
                "2200652",
                "2200654",
                "2200656",
                "2200658",
                "2707547",
                "2707549",
                "2707551",
                "2707553",
                "2707555",
                "2707557",
                "2736944",
                "2736946",
                "2736948"
              ],
              "spl_id": [
                "5176eed4-f8f8-4f88-a079-11f16864f40a"
              ],
              "spl_set_id": [
                "27f15fac-7d98-4114-a2ec-92494a91da98"
              ],
              "package_ndc": [
                "0169-1715-30",
                "0169-1715-90",
                "0169-1704-30",
                "0169-1709-30",
                "0169-4303-01",
                "0169-4303-13",
                "0169-4303-90",
                "0169-4303-93",
                "0169-4303-30",
                "0169-4303-99",
                "0169-4307-01",
                "0169-4307-13",
                "0169-4307-30",
                "0169-4314-01",
                "0169-4314-13",
                "0169-4314-30",
                "0169-4815-30",
                "0169-4815-90",
                "0169-4804-30",
                "0169-4809-30"
              ],
              "nui": [
                "N0000178480",
                "M0160181",
                "N0000020058"
              ],
              "pharm_class_epc": [
                "GLP-1 Receptor Agonist [EPC]"
              ],
              "pharm_class_cs": [
                "Glucagon-Like Peptide 1 [CS]"
              ],
              "pharm_class_moa": [
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
              ],
              "unii": [
                "53AXN4NNHX"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "OZEMPIC",
            "drugauthorizationnumb": "209637",
            "drugstructuredosagenumb": "0.5",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugadministrationroute": "058",
            "actiondrug": "4",
            "activesubstance": {
              "activesubstancename": "SEMAGLUTIDE"
            },
            "openfda": {
              "application_number": [
                "NDA213051"
              ],
              "brand_name": [
                "OZEMPIC"
              ],
              "generic_name": [
                "ORAL SEMAGLUTIDE"
              ],
              "manufacturer_name": [
                "Novo Nordisk Pharmaceutical Industries, LP"
              ],
              "product_ndc": [
                "0169-1704",
                "0169-1715",
                "0169-1709",
                "0169-4303",
                "0169-4307",
                "0169-4314",
                "0169-4815",
                "0169-4804",
                "0169-4809"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "SEMAGLUTIDE"
              ],
              "rxcui": [
                "2200644",
                "2200650",
                "2200652",
                "2200654",
                "2200656",
                "2200658",
                "2707547",
                "2707549",
                "2707551",
                "2707553",
                "2707555",
                "2707557",
                "2736944",
                "2736946",
                "2736948"
              ],
              "spl_id": [
                "5176eed4-f8f8-4f88-a079-11f16864f40a"
              ],
              "spl_set_id": [
                "27f15fac-7d98-4114-a2ec-92494a91da98"
              ],
              "package_ndc": [
                "0169-1715-30",
                "0169-1715-90",
                "0169-1704-30",
                "0169-1709-30",
                "0169-4303-01",
                "0169-4303-13",
                "0169-4303-90",
                "0169-4303-93",
                "0169-4303-30",
                "0169-4303-99",
                "0169-4307-01",
                "0169-4307-13",
                "0169-4307-30",
                "0169-4314-01",
                "0169-4314-13",
                "0169-4314-30",
                "0169-4815-30",
                "0169-4815-90",
                "0169-4804-30",
                "0169-4809-30"
              ],
              "nui": [
                "N0000178480",
                "M0160181",
                "N0000020058"
              ],
              "pharm_class_epc": [
                "GLP-1 Receptor Agonist [EPC]"
              ],
              "pharm_class_cs": [
                "Glucagon-Like Peptide 1 [CS]"
              ],
              "pharm_class_moa": [
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
              ],
              "unii": [
                "53AXN4NNHX"
              ]
            }
          }
        ]
      }
    }
  ]
}